183 related articles for article (PubMed ID: 38176714)
1. Design, Preclinical Evaluation, and Clinical Translation of
Zhao L; Pang Y; Fang J; Chen J; Zhou Y; Sun L; Wu H; Guo Z; Lin Q; Chen H
J Nucl Med; 2024 Mar; 65(3):394-401. PubMed ID: 38176714
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
3. Clinical translation of a novel FAPI dimer [
Tan Y; Li J; Zhao T; Zhou M; Liu K; Xiang S; Tang Y; Jakobsson V; Xu P; Chen X; Zhang J
Eur J Nucl Med Mol Imaging; 2024 Apr; ():. PubMed ID: 38561515
[TBL] [Abstract][Full Text] [Related]
4. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.
Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H
J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827
[TBL] [Abstract][Full Text] [Related]
5. A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of
Zhu W; Cheng Y; Jia R; Zhao H; Bai C; Xu J; Yao S; Huo L
J Nucl Med; 2021 Oct; 62(10):1398-1405. PubMed ID: 33579804
[No Abstract] [Full Text] [Related]
6. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
[TBL] [Abstract][Full Text] [Related]
7. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
[TBL] [Abstract][Full Text] [Related]
8. Clinical Evaluation of
Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H
J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301
[TBL] [Abstract][Full Text] [Related]
9. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
10. A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging.
Zhao X; Zhang G; Chen J; Li Z; Shi Y; Li G; Zhai C; Nie L
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1593-1604. PubMed ID: 38512485
[TBL] [Abstract][Full Text] [Related]
11. Radiosynthesis and First Preclinical Evaluation of the Novel
Wang C; Hu Z; Ding F; Zhao H; Du F; Lv C; Li L; Huang G; Liu J
Front Chem; 2022; 10():939160. PubMed ID: 35991604
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics.
Zhong X; Guo J; Han X; Wu W; Yang R; Zhang J; Shao G
Mol Pharm; 2023 May; 20(5):2402-2414. PubMed ID: 37015025
[TBL] [Abstract][Full Text] [Related]
13. [
Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
[TBL] [Abstract][Full Text] [Related]
14. Preclinical study and first-in-human imaging of [
Liu L; Zhong J; Zhang Z; Ye X; Wang X; Liu S; Zhang Z
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2012-2022. PubMed ID: 38326656
[TBL] [Abstract][Full Text] [Related]
15. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Wegen S; Claus K; Linde P; Rosenbrock J; Trommer M; Zander T; Tuchscherer A; Bruns C; Schlößer HA; Schröder W; Eich ML; Fischer T; Schomäcker K; Drzezga A; Kobe C; Roth KS; Weindler JJ
Radiat Oncol; 2024 Apr; 19(1):44. PubMed ID: 38575990
[TBL] [Abstract][Full Text] [Related]
16. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
[TBL] [Abstract][Full Text] [Related]
17.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
18.
Kline B; Yadav S; Seo Y; Ippisch RC; Castillo J; Aggarwal RR; Kelley RK; Behr SC; Flavell RR; Lawhn-Heath C; Melisko M; Rugo HS; Wang V; Yom SS; Ha P; Jiang F; Hope TA
J Nucl Med; 2024 Jun; 65(6):938-943. PubMed ID: 38697672
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of [
Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
